Status:
ACTIVE_NOT_RECRUITING
the Dutch-GERAF Study
Lead Sponsor:
Dijklander Ziekenhuis
Conditions:
Atrial Fibrillation
Frailty
Eligibility:
All Genders
65+ years
Brief Summary
Geriatric patients are at high risk of cardiovascular complications, and for the development of atrial fibrillation. Often atrial fibrillation exists in these patients without specific symptoms, and c...
Eligibility Criteria
Inclusion
- All newly referred patients of 65 years and older that visit geriatric outpatient services are eligible (including Fall clinic, Memory clinic, Pre-operative geriatric assessment clinic, or any other geriatric outpatient clinics that are led by a geriatrician).
Exclusion
- The patient has a pacemaker or implantable cardioverter defibrillator.
- The patient is known with a severe dementia, MoCA ≤ 15 points.
- The patient has a severe tremor, from whatever cause, and thus is unable to use the PPG based smartphone AF detection algorithm.
Key Trial Info
Start Date :
January 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2026
Estimated Enrollment :
1075 Patients enrolled
Trial Details
Trial ID
NCT05337202
Start Date
January 25 2021
End Date
June 30 2026
Last Update
February 20 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Rijnstate
Arnhem, Gelderland, Netherlands, 6815 AD
2
Dijklander Ziekenhuis
Hoorn, North Holland, Netherlands, 1624NP
3
Noordwest ziekenhuisgroep
Alkmaar, Netherlands, 1815 JD
4
Meander Medisch Centrum
Amersfoort, Netherlands, 3813 TZ